《新股》同仁堂醫養再提上市申請
北京同仁堂醫養再度提交主板上市申請,由中金公司擔任獨家保薦人。初步招股資料顯示,截至6月24日,該公司共擁有12家自有線下醫療機構及一家互聯網醫院,以及10家線下管理醫療機構,除通過自有醫療機構提供醫療服務外,亦有向機構客戶提供管理服務。
截至去年底止年度,同仁堂醫養錄收入11.75億元人民幣,按年增長1.9%,純利則增長逾65%至3,686.1萬元人民幣。公司預期,在港上市集資所得資金會用於擴充醫療服務網絡、提升醫療服務能力、償還銀行貸款及一般用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.